BioCentury
ARTICLE | Company News

20/20 GeneSystems, J&J deal

January 21, 2008 8:00 AM UTC

Johnson & Johnson's Ortho-Clinical Diagnostics subsidiary received a co-exclusive license to 20/20's blood test that identifies antibody responses to early stage non-small cell lung cancer (NSCLC). O...